Delivery Order SPE2DB20D1110-SPE2DB24FK18S
Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $2.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $10,925.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of the pharmaceutical product XIFAXAN 550 mg Tablet 60s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary...
- This federal contract award, valued at $16,368.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $79,357.76, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a Delivery Order contract valued at $2,944.99 to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product XIFAXAN 550 MG TABLET 60S, with a completion date of December 11, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $12,978.74, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $12,978.74 and an ultimate completion date of November 20, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $38,010.99 Firm Fixed Price Delivery Order is for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. This award is part of a larger Indefinite Delivery Contract (IDC) the DLA has with Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order valued at $42,891.12 for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award, valued at $1,316.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a performance period ending on March 11, 2024. This is a firm-fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,550.21 delivery order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,865.24, is for the delivery of XIFAXAN 550 MG Tablets 60s, a prescription medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through December 2025....